Enter assignee name

EPO Patents = 1

Trademarks = 9

Forward Citations = 3

Loading Chart...

18 inventors (with patents filed for the assignee):

Pierre Courtiol (6 out of 7 patents)

Gilles Wainrib (6 out of 7 patents)

Charles Maussion (4 out of 4 patents)

4. Charlie Saillard (3 out of 3 patents)

5. Benoit Schmauch (3 out of 3 patents)

6. Eric W Tramel (2 out of 3 patents)

7. Marc Sanselme (2 out of 3 patents)

8. Thomas Clozel (2 out of 2 patents)

9. Jean-Yves Blay (2 out of 4 patents)

10. Olivier Moindrot (2 out of 2 patents)

11. Aurelie Kamoun (1 out of 2 patents)

12. Françoise Galateau Sallé (1 out of 1 patent)

13. Françoise Galateau Salle (1 out of 1 patent)

14. Victor Aubert (1 out of 1 patent)

15. Magali Lacroix-Triki (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 12488899 - Systems and methods for determining breast cancer prognosis and associated features (2025-12-02),

2. 12249073 - Systems and methods for mesothelioma feature detection and enhanced prognosis or response to treatment (2025-03-11),

3. 12118721 - Systems and methods for image preprocessing (2024-10-15),

4. 12118715 - Systems and methods for image classification (2024-10-15),

5. 11562585 - Systems and methods for image preprocessing (2023-01-24),

6. 11544851 - Systems and methods for mesothelioma feature detection and enhanced prognosis or response to treatment (2023-01-03),

7. 11482022 - Systems and methods for image classification (2022-10-25),

Owkin, Inc. is a pioneering company in the field of artificial intelligence for healthcare. Founded in 2016, Owkin leverages machine learning and proprietary algorithms to accelerate drug discovery and optimize clinical trials, focusing on the intersection of AI and medical research. The company collaborates with leading academic institutions and pharmaceutical companies to harness the power of data from various sources, including medical records and imaging data, to create predictive models. This innovative approach aims to enhance patient outcomes, reduce costs, and streamline the drug development process. With a commitment to advancing science through technology, Owkin is at the forefront of transforming healthcare with AI-driven solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

7 Patents

#828 in New York, NY

#2,235 in New York

#38,762 in US

New York, NY, United States of America

Owkin, Inc.